Table 4.

Linear regression: association between RHI (dependent variable) and eGFR, adjusted to possible confounders.

	Beta	95% CI		p-Value
Model 1
Renal function (eGFR-CKD Epi)	0.007	0.004	0.010	<0.001
Model 2
Renal function (eGFR-CKD Epi)	0.005	0.001	0.008	0.010
Hypertension	−0.441	−0.758	−0.124	0.007
Model 3
Renal function (eGFR-CKD Epi)	0.006	0.003	0.009	<0.001
Diabetes	−0.192	−0.456	0.071	0.152
Model 4
Renal function (eGFR-CKD Epi)	0.006	0.003	0.009	<0.001
Dyslipidemia	−0.175	−0.415	0.064	0.150
Model 5
Renal function (eGFR-CKD Epi)	0.006	0.003	0.010	<0.001
Cerebrovascular disease	−0.251	−0.639	0.136	0.202
Model 6
Renal function (eGFR-CKD Epi)	0.007	0.003	0.010	<0.001
Cardiovascular disease	−0.085	−0.356	−187	0.538
Model 7
Renal function (eGFR-CKD Epi)	0.003	0.000	0.006	0.086
Age	−0.018	−0.026	−0.010	<0.001
Model 8
Renal function (eGFR-CKD Epi)	0.007	0.004	0.010	<0.001
Gender (male)	−0.128	−0.356	0.101	0.272
Model 9
Renal function (eGFR-CKD Epi)	0.005	0.002	0.009	0.001
Body Mass Index	−0.017	−0.036	−0.003	0.096
Model 10
Renal function (eGFR-CKD Epi)	0.006	0.003	0.009	0.001
Systolic Blood Pressure	−0.006	−0.011	0.000	0.041
Model 11
Renal function (eGFR-CKD Epi)	0.007	0.004	0.010	<0.001
Albuminuria	−0.008	−0.031	0.014	0.460
Model 12
Renal function (eGFR-CKD Epi)	0.004	0.000	0.007	0.047
Hypertension	−0.390	−0.725	−0.055	0.023
Diabetes	−0.164	−0.459	0.130	0.271
Dyslipidemia	−0.075	−0.328	0.178	0.557
Cerebrovascular disease	−0.228	−0.625	0.169	0.258
Cardiovascular disease	0.084	−0.221	0.388	0.587
Model 12
Renal function (eGFR-CKD Epi)	0.002	−0.002	0.006	0.367
Hypertension	−0.165	−0.509	0.180	0.345
Diabetes	−0.031	−0.339	0.276	0.840
Dyslipidemia	0.040	−0.346	0.425	0.838
Cerebrovascular disease	0.198	−0.129	0.525	0.232
Cardiovascular disease	−0.015	−0.443	0.413	0.945
Age	−0.014	−0.023	−0.005	0.003
Gender	−0.085	−0.339	0.170	0.510
Body Mass Index	−0.017	−0.038	0.004	0.119
Albuminuria	−0.004	−0.033	0.026	0.812